parodontax (GlaxoSmithKline Consumer Healthcare Holdings (US) LLC)
Welcome to the PulseAid listing for the parodontax drug offered from GlaxoSmithKline Consumer Healthcare Holdings (US) LLC. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC |
NON-PROPRIETARY NAME: | stannous fluoride |
SUBSTANCE NAME: | STANNOUS FLUORIDE |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | DENTAL |
DOSAGE FORM: | PASTE |
MARKETING CATEGORY NAME: | OTC MONOGRAPH NOT FINAL |
START MARKETING DATE: | 2016-12-19 |
END MARKETING DATE: | 0000-00-00 |
parodontax HUMAN OTC DRUG Details:
Item Description | parodontax from GlaxoSmithKline Consumer Healthcare Holdings (US) LLC |
LABELER NAME: | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 1.5(mg/g) |
START MARKETING DATE: | 2016-12-19 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0135-0598_0f07aa1a-97be-44af-92d8-a10777e24e0a |
PRODUCT NDC: | 0135-0598 |
APPLICATION NUMBER: | part356 |
Other STANNOUS FLUORIDE Pharmaceutical Manufacturers / Labelers: